Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bejan-Angoulvant

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 7, 2014
[Drugs news]T Bejan-Angoulvant, F Beau-Salinas, C Lengellé, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 28, 2014
[Drugs news]T Bejan-Angoulvant, F Beau-Salinas, C Lengellé, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|August 9, 2014
[Drugs news]T Bejan-Angoulvant, F Beau-Salinas, C Lengellé, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|April 28, 2016
[Drugs news]F Beau-Salinas, C Lengellé, T Bejan-Angoulvant, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 3, 2016
[Drugs news]M-S Agier, F Beau-Salinas, T Bejan-Angoulvant, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|September 27, 2016
[Drugs news]M-S Agier, C Lengellé, T Bejan-Angoulvant, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|May 15, 2016
[Drugs news]M-S Agier, F Beau-Salinas, C Lengellé, et al.
Diabetes & Metabolism|May 11, 2015
Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?T Bejan-Angoulvant, C Cornu, P Archambault, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 3, 2017
[Drugs news]L Vrignaud, C Simon, M-S Agier, et al.
Diabetes & Metabolism|June 1, 2019
Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysisG Grenet, H H Le, T Bejan-Angoulvant, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 7, 2014
[Drugs news]T Bejan-Angoulvant, F Beau-Salinas, C Lengellé, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 28, 2014
[Drugs news]T Bejan-Angoulvant, F Beau-Salinas, C Lengellé, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|August 9, 2014
[Drugs news]T Bejan-Angoulvant, F Beau-Salinas, C Lengellé, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|April 28, 2016
[Drugs news]F Beau-Salinas, C Lengellé, T Bejan-Angoulvant, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 3, 2016
[Drugs news]M-S Agier, F Beau-Salinas, T Bejan-Angoulvant, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|September 27, 2016
[Drugs news]M-S Agier, C Lengellé, T Bejan-Angoulvant, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|May 15, 2016
[Drugs news]M-S Agier, F Beau-Salinas, C Lengellé, et al.
Diabetes & Metabolism|May 11, 2015
Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?T Bejan-Angoulvant, C Cornu, P Archambault, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 3, 2017
[Drugs news]L Vrignaud, C Simon, M-S Agier, et al.
Diabetes & Metabolism|June 1, 2019
Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysisG Grenet, H H Le, T Bejan-Angoulvant, et al.
Pageof 3